Company · CIK 0001034842 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
RIGEL PHARMACEUTICALS INC · RIGL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 FMForm 4 → | Sep 3, 7:02 pm EDT | Dean L SchornoEVP & Chief Financial Officer | 5,528 | $26.05 | $144,009 | 82,962 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 7:01 pm EDT | David A SantosEVP, Chief Commercial Officer | 874 | $47.50 | $41,515 | 61,622 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 6:59 pm EDT | Raul R RodriguezCEO, President, Director | 2,424 | $47.50 | $115,140 | 273,362 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 6:59 pm EDT | Raymond J. FureyEVP, GC, CCO & Corp Sec | 877 | $47.50 | $41,658 | 50,559 | — | |
| Jul 8, 2026 AForm 4 → | Jul 10, 9:53 pm EDT | Alison L. HannahEVP, Chief Medical Officer | 24,400 | — | — | 35,025 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 MForm 4 → | Sep 3, 7:02 pm EDT | Dean L SchornoEVP & Chief Financial Officer | 4,600 | — | — | 15,867 | — |